← Browse by Condition
Medical Condition
axial spondylarthritis axspa
Total Trials
2
Recruiting Now
2
Trial Phases
Various
NCT07166315
Recruiting
Treatment Effectiveness in People With axSpA or PsA Starting Treatment With Bimekizumab, Risankizumab, Guselkumab, Upadacitinib, or a TNF Inhibitor
Enrollment
700 pts
Location
United Kingdom
Sponsor
Adelphi Real World
NCT07150000
Recruiting
Clinical Assessment for Rheumatologic Disease - Research and Advancement in Safety and Efficacy
Enrollment
120 pts
Location
Germany
Sponsor
University of Bonn